Evidence map›Paper›PMID 33797635›Full record

Trial reportClinical oral investigations2021

Randomized controlled clinical trial of a highly filled flowable composite in non-carious cervical lesions: 3-year results.

Haiying Zhang, Luxuan Wang, Lin Hua, Rui Guan, Benxiang Hou

Registry-linked trialAbstract readRandomized Controlled Trial
PubMed Publisher
In one paragraph

Trial report in Clinical oral investigations, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07128589 (Clinical Evaluation of 3M), which is not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07128589 narecruitingnot on this mapstarted 2025, after this paper: background citation

Clinical Evaluation of 3M(TM) Filtek(TM) Supreme Flowable Composites for Class IV and Veneers

TypeinterventionalSponsorNew York UniversityRan2025 to 2028Enrolled75ConditionsDental Restoration, Dental VeneersArms3MTM FiltekTM Supreme Flowable Composite
3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Haiying ZhangDepartment of Endodontics, Beijing Stomatological Hospital, Capital Medical University, Beijing, China.ORCID http://orcid.org/0000-0001-7052-8968
Luxuan WangDepartment of Endodontics, Beijing Stomatological Hospital, Capital Medical University, Beijing, China.
Lin HuaSchool of Biomedical Engineering, Capital Medical University, Beijing, China.
Rui GuanDepartment of Endodontics, Beijing Stomatological Hospital, Capital Medical University, Beijing, China.
Benxiang HouDepartment of Endodontics, Beijing Stomatological Hospital, Capital Medical University, Beijing, China. houbenxiang@gmail.com.

Funding

Beijing Municipal Administration of Hospitals Incubating Program PX2017025Scientific Research Common Program of Beijing Municipal Commission of Education KM201810025026
6 · The paper itself

Abstract

objectivesThis prospective, randomized, split-mouth clinical trial assessed the 3-year clinical performance of a highly filled flowable composite and a conventional paste-type composite in non-carious cervical lesions (NCCLs). MATERIALS AND

methodsA total of 84 NCCLs in 27 subjects were included in this split-mouth design study and randomly divided into two groups: a highly filled flowable composite Clearfil Majesty ES Flow group (ES, n = 42) and a conventional paste-type composite Majesty group (MJ, n = 42). Clearfil SE Bond was used following the manufacturer's instructions. The restorations were evaluated at baseline (BL) and 1, 2, and 3 years using FDI (World Dental Federation) criteria. Data were analysed by a paired chi-squared test for intergroup comparisons and the Friedman test for intragroup comparisons (α = 0.05).

resultsBoth groups had a 97.3% retention rate at the 3-year evaluation. The acceptable scores (FDI scores 1-3) for each criterion exhibited no significant difference between the MJ and ES groups at any time point (p = 1.00). The marginal adaptation performance of ES was significantly better than that of MJ at every evaluation point (p < 0.05).

conclusionsThe 3-year clinical performance of ES in NCCLs was similar to that of MJ. When the restorations were clinically acceptable, ES showed better marginal adaptation than MJ. CLINICAL RELEVANCE: Compared with conventional paste-type composites, highly filled flowable composites showed similar clinical performance and better marginal adaptation for restoring NCCLs after 3 years.

trial registrationTRN: ChiCTR1900028484 . Date of registration: December 22, 2019, retrospectively registered.

Indexed as

Dental Marginal AdaptationDental Restoration, PermanentComposite ResinsHumansMouthProspective StudiesResin CementsComposite Resinsflowable hybrid compositeResin CementsClinical performanceFlowable compositeMarginal adaptationNon-carious cervical lesions

Identifiers

PMID33797635

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.